EP1175439A4 - 49 human secreted proteins - Google Patents

49 human secreted proteins

Info

Publication number: EP1175439A4
Authority: EP; European Patent Office
Prior art keywords: secreted proteins; human secreted; human; proteins; secreted
Prior art date: 1999-04-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00921732A

Other languages

German (de)

French (fr)

Other versions

EP1175439A1 (en

Inventor

Steven M Ruben

George Komatsoulis

Craig A Rosen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-09

Filing date

2000-04-06

Publication date

2002-10-09

2000-04-06 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2002-01-30 Publication of EP1175439A1 publication Critical patent/EP1175439A1/en

2002-10-09 Publication of EP1175439A4 publication Critical patent/EP1175439A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP00921732A 1999-04-09 2000-04-06 49 human secreted proteins Withdrawn EP1175439A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US12869499P	1999-04-09	1999-04-09
US128694P		1999-04-09
US17693100P	2000-01-20	2000-01-20
US176931P		2000-01-20
PCT/US2000/009071 WO2000061629A1 (en)	1999-04-09	2000-04-06	49 human secreted proteins

Publications (2)

Publication Number	Publication Date
EP1175439A1 EP1175439A1 (en)	2002-01-30
EP1175439A4 true EP1175439A4 (en)	2002-10-09

Family

ID=26826853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00921732A Withdrawn EP1175439A4 (en)	1999-04-09	2000-04-06	49 human secreted proteins

Country Status (5)

Country	Link
EP (1)	EP1175439A4 (en)
JP (1)	JP2003501011A (en)
AU (1)	AU4200900A (en)
CA (1)	CA2370489A1 (en)
WO (1)	WO2000061629A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030232056A1 (en)	1999-09-10	2003-12-18	Corixa Corporation	Compositions and methods for the therapy and diagnosis of ovarian cancer
US6710170B2 (en)	1999-09-10	2004-03-23	Corixa Corporation	Compositions and methods for the therapy and diagnosis of ovarian cancer
EP1280937A2 (en) *	2000-04-26	2003-02-05	Millennium Pharmaceuticals, Inc.	Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU6531101A (en) *	2000-06-02	2001-12-17	Genentech Inc	Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2008289482A (en) *	2000-11-14	2008-12-04	Corixa Corp	Composition and method for therapy and diagnosis of ovarian cancer
US7157558B2 (en)	2001-06-01	2007-01-02	Genentech, Inc.	Polypeptide encoded by a polynucleotide overexpresses in tumors
WO2003020307A1 (en) *	2001-08-31	2003-03-13	The General Hospital Corporation	Bone morphogenic protein 2-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
US20050123925A1 (en)	2002-11-15	2005-06-09	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of tumor
RU2392966C2 (en)	2004-07-20	2010-06-27	Дженентек, Инк.	Angiopoietic angiopoietin-like protein 4 inhibitors, in combinations and application
BRPI0513477A (en)	2004-07-20	2008-05-06	Genentech Inc	Angiotensin-like protein 4 compositions and processes
US8604185B2 (en)	2004-07-20	2013-12-10	Genentech, Inc.	Inhibitors of angiopoietin-like 4 protein, combinations, and their use
AR059900A1 (en)	2006-03-17	2008-05-07	Genentech Inc	ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS
BRPI0807635A2 (en) *	2007-02-22	2014-06-03	Genentech Inc	METHODS FOR DETECTION OF INFLAMMATORY INFLAMMATORY DISEASE
CN104745669A (en) *	2009-01-21	2015-07-01	麻省理工学院	Compositions and methods for evaluating cytotoxicity of single cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5654139A (en) *	1994-09-21	1997-08-05	The United States Of America As Represented By The Department Of Health And Human Services	Allelic variation of the serotonin 5HT2c receptor

2000
- 2000-04-06 AU AU42009/00A patent/AU4200900A/en not_active Abandoned
- 2000-04-06 WO PCT/US2000/009071 patent/WO2000061629A1/en not_active Application Discontinuation
- 2000-04-06 CA CA002370489A patent/CA2370489A1/en not_active Abandoned
- 2000-04-06 JP JP2000611570A patent/JP2003501011A/en not_active Withdrawn
- 2000-04-06 EP EP00921732A patent/EP1175439A4/en not_active Withdrawn

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] "Human DNA sequence from clone RP1-68O2 on chromosome 22", XP002198453, Database accession no. Z82215 *
See also references of WO0061629A1 *

Also Published As

Publication number	Publication date
EP1175439A1 (en)	2002-01-30
AU4200900A (en)	2000-11-14
WO2000061629A1 (en)	2000-10-19
JP2003501011A (en)	2003-01-14
CA2370489A1 (en)	2000-10-19

Publication	Publication Date	Title
EP1218408A4 (en)	2003-02-26	32 human secreted proteins
EP1212343A4 (en)	2004-11-03	52 human secreted proteins
EP1181390A4 (en)	2004-08-04	27 human secreted proteins
EP1224285A4 (en)	2004-12-08	27 human secreted proteins
EP1212342A4 (en)	2003-04-02	18 human secreted proteins
EP1226231A4 (en)	2003-07-09	19 human secreted proteins
EP1175438A4 (en)	2002-10-30	62 human secreted proteins
EP1192176A4 (en)	2003-03-05	49 human secreted proteins
EP1192278A4 (en)	2003-05-28	48 human secreted proteins
EP1165827A4 (en)	2003-05-02	45 human secreted proteins
EP1175439A4 (en)	2002-10-09	49 human secreted proteins
EP1159284A4 (en)	2003-10-29	33 human secreted proteins
EP1189917A4 (en)	2003-11-05	48 human secreted proteins
EP1185543A4 (en)	2003-09-03	50 human secreted proteins
EP1203005A4 (en)	2004-11-24	25 human secreted proteins
EP1173477A4 (en)	2003-02-26	49 human secreted proteins
EP1224201A4 (en)	2005-03-02	32 human secreted proteins
EP1206573A4 (en)	2004-08-04	26 human secreted proteins
EP1169332A4 (en)	2003-09-03	49 human secreted proteins
EP1171460A4 (en)	2002-10-09	48 human secreted proteins
EP1165602A4 (en)	2002-10-09	49 human secreted proteins
EP1144614A4 (en)	2003-08-06	33 human secreted proteins
EP1165828A4 (en)	2002-09-25	50 human secreted proteins
EP1228082A4 (en)	2005-11-16	29 human secreted proteins
EP1185285A4 (en)	2003-02-19	49 human secreted proteins

Legal Events

Date	Code	Title	Description
2001-12-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-01-30	17P	Request for examination filed	Effective date: 20011108
2002-01-30	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-01-30	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2002-10-09	A4	Supplementary search report drawn up and despatched	Effective date: 20020827
2002-10-09	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2004-05-06	17Q	First examination report despatched	Effective date: 20040319
2004-12-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-02-02	18D	Application deemed to be withdrawn	Effective date: 20040730